Virologic (NASDAQ:VLGC)
Historical Stock Chart
From Feb 2020 to Feb 2025
![Click Here for more Virologic Charts. Click Here for more Virologic Charts.](/p.php?pid=staticchart&s=N%5EVLGC&p=8&t=15)
ViroLogic Announces Second Quarter 2005 Financial Results
Conference Call
SOUTH SAN FRANCISCO, Calif., July 19 /PRNewswire-FirstCall/ -- ViroLogic, Inc.
(NASDAQ:VLGC), announced that it will hold a conference call on Monday, July 25,
2005 at 10:00 a.m. Eastern Time to discuss second quarter 2005 financial
results. The call will be hosted by Mr. William D. Young, Chairman & CEO of
ViroLogic, Inc.
To participate in the live teleconference please call 800-299-9630 fifteen
minutes before the conference begins. International callers please dial
617-786-2904. Conference participant passcode is 50668032. Live audio of the
call will be simultaneously broadcast over the Internet and will be available
to members of the news media, investors and the general public. Access to live
and archived audio of the conference call will be available by following the
appropriate links at http://www.virologic.com/ and clicking on the Investor
Relations link. Following the live broadcast, a replay of the call will also be
available at 888-286-8010 or 617-801-6888 for international callers, until
August 5, 2005. The replay passcode is 28160002.
The information provided on the teleconference is only accurate at the time of
the conference call, and ViroLogic will take no responsibility for providing
updated information except as required by law.
About ViroLogic
ViroLogic is a biotechnology company advancing individualized medicine by
discovering, developing and marketing innovative products to guide and improve
treatment of serious infectious diseases and cancer. The Company's products are
designed to help doctors optimize treatment regimens for their patients that
lead to better outcomes and reduced costs. The Company's technology is also
being used by numerous biopharmaceutical companies to develop new and improved
antiviral therapeutics and vaccines as well as targeted cancer therapeutics.
More information about the Company and its technology can be found on its web
site at http://www.virologic.com/.
DATASOURCE: ViroLogic, Inc.
CONTACT: Alfred Merriweather, Vice President and CFO of ViroLogic, Inc.,
+1-650-635-1100; or Daryl Messinger of WeissComm Partners, +1-415-999-2361, or
, for ViroLogic, Inc.
Web site: http://www.virologic.com/